Samik Upadhaya, Ph.D., CRI Assistant Director, Scientific Affairs, speaks on the “Incorporating Advances in Biomarker Development to Inform Clinical Decisions and Lessons Learned” panel at 5:20 PM ET on Thursday, March 17, 2022.
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
The 8th Annual Immuno-Oncology 360° delivers three key benefits:
- Access to key opinion leaders driving the science
- Partnership opportunities with all stakeholders in immuno-oncology
- Presentations on the latest data impacting the science, clinical and business advancements in immuno-oncology
Learn more at io360summit.com
Photo by Jorge Gardner on Unsplash